Kuidas keskusega ühendust võtta
HCP keskus
Rigshospitaleti ajalooline taust ulatub tagasi Taani esimese päris haiglasse "The Royal Frederiks Hospital", mis loodi vaeste Kopenhaagenlaste hooldamiseks ja raviks kiindumusega. Haigla avati 1757. aastal ja asus Bredgades, kus täna asub Kunstindustrimuseet. 1910. aastal sai haigla osariigi osaks ja kolis oma praegusesse asukohta Blegdamsvej. Haigla muutis ka oma nime Rigshospitaletiks, kuna see peaks tulevikus olema kättesaadav kõigile kuningriigi kodanikele. Kaasaegne Rigshospital oma kõrgete hallide hoonetega pärineb 1960. aastatest ja on tänapäeval osa pealinnapiirkonnast.
Pilt : Ole Morten Nygård
Saada sõnum
Rigshospitalet, Copenhagen, Denmark
meeskond
Dr Steffen HAMANN
Taani
Pr Michael LARSEN
Taani
Line Kessel
Taani
Kliinilised uuringud
A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients with Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy
TENecteplase in Central Retinal Artery Occlusion Study (TenCRAOS): A Randomized Placebo-controlled Trial of Early Systemic Tenecteplase Treatment in Patients With Central Retinal Artery Occlusion.
This is a single-arm open label interventional safety trial with RP patients, who receive weekly TES for 6 months on 1 eye followed by observation for another 6 months without stimulation. The primary outcome measure is safety, indicated by the frequency and severity of adverse events.
Natural history of patients with inherited retinal diseases due to mutations in RPE65 gene
Safety and Efficacy of Emixustat in Stargardt Disease.
Efficacy and safety of QLT091001 in subjects with Inherited Retinal Disease (IRD) caused by gene mutations.
A Long-term Follow-up Study to Evaluate the Safety and efficacy of Retinal Gene Therapy in Subjects with choroideremia treated previously with Adeno-Associated Viral Vector Encoding Rab Escort Protein-1 (AAV2-REP1) in an Antecedent Study.
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber’s Hereditary Optic Neuropathy (LHON).
Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT.
Clinical and Genetic Examination of Usher Syndrome Patients’ Cohort in Europe.
A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Long-Term Non-Interventional Latanoprost Study
Advanced Characterization of Autosomal Dominant Optic Atrophy.
Transcorneal Electrical Stimulation - Multicenter Safety Study.
Identification and Verification of Candidate Genes Responsible for Optic Disc Drusen
Non-Arteritic Anterior Ischemic Optic Neuropathy Risk Factors: New Perspectives
A Head-to-head Comparison of Ultrasound Versus Temporal Artery Biopsy in the Diagnosis of Giant Cell Arteritis
Global Patient Registry of Inherited Retinal Disease